Evaxion Biotech AS (EVAX)
2.64
+0.05
(+1.93%)
USD |
NASDAQ |
Nov 04, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Price to Book Value: 199.00 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 195.23 |
| October 31, 2024 | 201.26 |
| October 30, 2024 | 208.05 |
| October 29, 2024 | 219.36 |
| October 28, 2024 | 214.08 |
| October 25, 2024 | 208.05 |
| October 24, 2024 | 199.76 |
| October 23, 2024 | 201.26 |
| October 22, 2024 | 192.97 |
| October 21, 2024 | 191.46 |
| October 18, 2024 | 199.00 |
| October 17, 2024 | 204.28 |
| October 16, 2024 | 204.28 |
| October 15, 2024 | 195.99 |
| October 14, 2024 | 202.77 |
| October 11, 2024 | 195.99 |
| October 10, 2024 | 198.25 |
| October 09, 2024 | 202.02 |
| October 08, 2024 | 214.08 |
| October 07, 2024 | 214.83 |
| October 04, 2024 | 222.37 |
| October 03, 2024 | 230.66 |
| October 02, 2024 | 224.63 |
| October 01, 2024 | 220.86 |
| September 30, 2024 | 234.43 |
| Date | Value |
|---|---|
| September 27, 2024 | 13.89 |
| September 26, 2024 | 13.62 |
| September 25, 2024 | 12.60 |
| September 24, 2024 | 13.22 |
| September 23, 2024 | 13.13 |
| September 20, 2024 | 13.31 |
| September 19, 2024 | 14.02 |
| September 18, 2024 | 13.89 |
| September 17, 2024 | 13.49 |
| September 16, 2024 | 14.47 |
| September 13, 2024 | 13.36 |
| September 12, 2024 | 13.62 |
| September 11, 2024 | 13.98 |
| September 10, 2024 | 14.25 |
| September 09, 2024 | 14.47 |
| September 06, 2024 | 15.36 |
| September 05, 2024 | 14.33 |
| September 04, 2024 | 15.18 |
| September 03, 2024 | 14.06 |
| August 30, 2024 | 13.57 |
| August 29, 2024 | 14.82 |
| August 28, 2024 | 13.40 |
| August 27, 2024 | 14.20 |
| August 26, 2024 | 13.71 |
| August 23, 2024 | 13.97 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.410
Minimum
Jun 17 2022
234.43
Maximum
Sep 30 2024
14.21
Average
4.807
Median
Apr 22 2021
Price to Book Value Benchmarks
| Ascendis Pharma AS | -- |
| Novo Nordisk AS | 30.23 |
| DBV Technologies SA | 0.9524 |
| Adaptimmune Therapeutics PLC | 2.190 |
| Akari Therapeutics PLC | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.658 |
| Price | 2.64 |
| Earnings Yield | -106.1% |
| Market Cap | 14.72M |